Search Within

Dmitriy Zamarin

  1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (2)
  3. Book Section (1)
Groups
  1. Center for Hematologic Malignancies (7)
  2. Department of Medicine (7)
  3. GDMT, Medicine (7)
  4. Gynecologic Medicine Service (7)
  5. Gynecology Disease Management Team (7)
  6. Hematologic Malignancies Research (7)

More Groups

People
  1. Alexander Lesokhin (7)
  2. Danielle Chimento (4)
  3. David Chung (4)
  4. Hani Hassoun (4)
  5. Heather Landau (4)
  6. Nikoletta Lendvai (4)

More People

Years
  1. 2016 (1)
  2. 2014 (2)
  3. 2013 (2)
  4. 2012 (1)
  5. 2011 (1)
Publications
  1. Blood (2)
  2. Bone Marrow Transplantation (1)
  3. Current Opinion in Oncology (1)
  4. EBioMedicine (1)
  5. Leukemia (1)
  6. Pocket Oncology (1)
Publishers
  1. American Society of Hematology (2)
  2. Nature Publishing Group (2)
  3. Elsevier Inc. (1)
  4. Lippincott Williams & Wilkins (1)
  5. Wolters Kluwer Health | Lippincott Williams & Wilkins (1)

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting myeloid-derived suppressor cells with colony stimulating factor-1 receptor blockade can reverse immune resistance to immunotherapy in indoleamine 2,3-dioxygenase-expressing tumors
    Journal Article

    Holmgaard, R. B.; Zamarin, D.; Lesokhin, A.; Merghoub, T.; Wolchok, J. D.
    EBioMedicine (2016)

    Fulltext@MSK | Save
  • Harnessing the immune system for cancer therapy
    Journal Article

    Smith, E. L.; Zamarin, D.; Lesokhin, A. M.
    Current Opinion in Oncology (2014)

    Fulltext@MSK | Save
  • Cancer immunology
    Book Section

    Hobbs, G.; Lesokhin, A. M.; Zamarin, D.; Wolchok, J. D.
    In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

    Fulltext@MSK | Save
  • Polyclonal immune activation and marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy: Incidence and prognostic significance
    Journal Article

    Zamarin, D.; Devlin, S. M.; Arcila, M. E.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D. J.; Chimento, D.; Weltz, J.; Babu, D.; more...
    Leukemia (2013)

    Fulltext@MSK | Save
  • Patterns of relapse and progression in multiple myeloma patients after auto-SCT: Implications for patients' monitoring after transplantation
    Journal Article

    Zamarin, D.; Giralt, S.; Landau, H.; Lendvai, N.; Lesokhin, A.; Chung, D.; Koehne, G.; Chimento, D.; Devlin, S. M.; Riedel, E.; more...
    Bone Marrow Transplantation (2013)

    Fulltext@MSK | Save
  • Reactive polyclonal gammopathy associated with polyclonal plasmacytosis is common in patients with multiple myeloma receiving prolonged lenalidomide therapy: A retrospective study of 104 patients
    Meeting Abstract

    Zamarin, D.; Devlin, S.; Arcila, M.; Giralt, S. A.; Landau, H.; Lesokhin, A.; Lendvai, N.; Chung, D.; Chimento, D.; Babu, D.; more...
    Blood (2012)

    Fulltext@MSK | Save
  • Patterns of disease relapse and progression in patients with multiple myeloma after first line therapy with autologous stem cell transplantation: Implications for patient monitoring after transplantation
    Meeting Abstract

    Zamarin, D.; Bhutani, M.; Chimento, D.; Giralt, S.; Lendvai, N.; Landau, H.; Lesokhin, A.; Chung, D.; Babu, D.; Hassoun, H.
    Blood (2011)

    Fulltext@MSK | Save